4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮
4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮结构式
|
常用名 | 4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮 | 英文名 | 4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one |
|---|---|---|---|---|
| CAS号 | 80841-78-7 | 分子量 | 148.544 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | 163.2±42.0 °C at 760 mmHg | |
| 分子式 | C5H5ClO3 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 66.7±26.9 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
|
Synthesis and Physicochemical Characterization of the Process-Related Impurities of Olmesartan Medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist?
Molecules 20 , 21346-63, (2015) During the process development for multigram-scale synthesis of olmesartan medoxomil (OM), two principal regioisomeric process-related impurities were observed along with the final active pharmaceutical ingredient (API). The impurities were identified as N-1-... |
期刊文献综述：
更多...